NGVT
Ingevity Corporation · Basic Materials · Chemicals - Specialty
Momentum-inputs (vergelijkbare managers):
breedte van houders +9.1% ·
aandelenstroom +2.1% ·
netto nieuwe posities +8.3%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q1 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 103 | +2 | 24.32M | $1.82B | +9 | −6 |
| Q1 2026 | 103 | +2 | 24.86M | $1.77B | +8 | −6 |
| Q4 2025 | 101 | 0 | 27.65M | $1.64B | — | — |
| Q3 2025 | 21 | +2 | 17.28M | $953.51M | +2 | — |
| Q2 2025 | 16 | +1 | 16.56M | $713.77M | +1 | — |
| Q1 2025 | 12 | +1 | 6.33M | $250.43M | +1 | — |
| Q4 2024 | 11 | 0 | 6.19M | $252.36M | — | — |
| Q3 2024 | 10 | -3 | 4.46M | $174.12M | — | −3 |
| Q2 2024 | 13 | — | 4.12M | $179.92M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 2.30M | +2.6% | $91.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | Wellington Management ✦ | 2.30M | +2.6% | $91.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.30M | +2.6% | $91.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.30M | +2.6% | $91.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.30M | +2.6% | $91.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.30M | +2.6% | $91.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | State Street Global Advisors ✦ (passief) | 1.55M | -4.0% | $61.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Millennium Management ✦ | 1.23M | +8.0% | $48.54M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passief) | 838.84K | +3.0% | $33.22M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passief) | 838.84K | +3.0% | $33.22M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Marshall Wace ✦ | 174.46K | -15.7% | $6.91M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Marshall Wace ✦ | 174.46K | -15.7% | $6.91M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | PRIMECAP Management ✦ | 69.00K | 0.0% | $2.73M | 0.0% | Held | 4 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 42.26K | +347.8% | $1.67M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 42.26K | +347.8% | $1.67M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 37.85K | +7.4% | $1.50M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 37.85K | +7.4% | $1.50M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 33.10K | Nieuw | $1.31M | 0.0% | New | 1 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 22.31K | -24.0% | $883,213 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 21.17K | -27.4% | $838,002 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 13.41K | +10.9% | $518,430 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 13.41K | +10.9% | $518,430 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 13.41K | +10.9% | $518,430 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 13.41K | +10.9% | $518,430 | 0.0% | ▲ Add | 4 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Renaissance Technologies | $1.31M | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 303 houders, 35.66M aandelen, $2.45B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer, Director · 92 aand · $6,873
Officer, Director · 5.00K aand · $379,150
Officer, Director · 5.00K aand · $378,650
Officer, Director · 5.00K aand · $378,650
Officer, Director · 5.00K aand · $383,100
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie